Floatz logo

Tetrathiomolybdate

Wilson Disease

National Center for Research Resources (NCRR)Phase 3Dormant
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
89/ 100

Competitive context

12 Active assets in the Wilson Disease cohort.

Asset / SponsorPhaseRating
ZINC ACETATE
Nobelpharma
Phase 4BBB
Teta 4Hcl
Orphalan
Phase 3BBB
ZINC D-GLUCONATE (1:2)
Jun Li
Phase 4BBB
Trientine
Excelsior
Phase 3BB
Penicillamine
Orphalan
Phase 3BB

View all 21 →

Same molecule, other indications

Tetrathiomolybdate is also rated in:

primary biliary cholangitisDormant
BB
Indicative ·
64 / 100
View asset →
hepatocellular carcinomaDormant
B
Indicative ·
57 / 100
View asset →
colorectal carcinomaDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →